First Portable Vein Illumination Device by AccuVein, Now Available on GSA Schedule

Cold Spring Harbor, NY, June 29 /PRNewswire/ AccuVein today announced a five-year agreement with the U.S. General Services Administration (GSA). This agreement brings the world’s first hand-held, non-contact vein illumination device, to GSA organizations including military and veteran hospitals.

Vein illumination with AccuVein helps healthcare professionals locate hard-to-find veins. IV starts, blood draws and blood donation (venipuncture) can be a source of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks. Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The device can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.

“Adding AccuVein’s breakthrough device on the GSA schedule brings a valuable device to these healthcare professionals at the front-line of patient care, enabling them to see a vein map on the skin to improve the time, comfort and cost of care,” said Stephen P. Conlon, President, AccuVein. “We’ve had strong interest from a broad range of Military, Federal and State medical institutions and the GSA agreement enables greater access to this important advancement in patient care.”

Weighing only 10 ounces, the device uses point-and-click technology — the healthcare professional simply presses a button and positions the device above the patient’s skin to display a map on the skin of underlying veins. With a range of hands-free options, AccuVein’s breakthrough device can quickly switch between a hand-held and hands-free mode, freeing the practitioner’s hands to perform the venipuncture.

Government organizations that can purchase the device from the GSA Schedule include:

• The Department of Health and Human Services
• Indian Health Service and the Office of Tribal Programs
• Department of Justice
• Federal Bureau of Prisons
• Department of Defense
• VA Medical Centers, Clinics and Military Hospitals

For more information and to see videos of the device in action, please visit www.accuvein.com. AccuVein representatives will also be on-site at the American Association for Clinical Chemistry Annual Meeting and Clinical Lab Expo, Booth 1572, July 19-23, in Chicago, Illinois.

About AccuVein

AccuVein is a global leader in medical imaging solutions. Its breakthrough product, the AV300, allows health care professionals to see a map of peripheral veins on the skin’s surface with the goal of improving venipuncture and other vascular access procedures. The AV300 is the world’s only handheld, non-contact vein illumination solution. It is built on AccuVein’s proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. It is in use at more than 1000 hospitals and available for sale in 88 countries. For more information please visit www.accuvein.com

For more information on the AccuVein, please visit www.accuvein.com.

About GSA

GSA provides a centralized delivery system of products and services to the federal government, leveraging its enormous buying power to get the best value for taxpayers.

• Founded in 1949, GSA manages more than one-fourth of the government’s total procurement dollars and influences the management of $500 billion in federal assets, including 8,600 government-owned or leased buildings and 213,000 vehicles.
• GSA helps preserve our past and define our future, as a steward of more than 480 historic properties, and as manager of USA.gov, the official portal to federal government information and services.
• GSA’s mission to provide superior workplaces, expert technology solutions, acquisition services, purchasing and E-Gov travel solutions and management policies, at best value, allows federal agencies to focus on their core missions.

More information is available at http://www.gsa.gov.

Contact:

For Media Inquiries:
Heidi Siegel
AccuVein
631-367-0393
heidi@accuvein.com